Targeting CD22 for B-cell hematologic malignancies.

Xu, Jia; Luo, Wenjing; Li, Chenggong; Mei, Heng.

Afiliação

Xu J; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China.
Luo W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
Li C; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China.
Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.

Exp Hematol Oncol ; 12(1): 90, 2023 Oct 11.

Article em En | MEDLINE | ID: mdl-37821931